Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | AMGN | VRTX | REGN | GILD |
| Company | Anaptysbio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 34.34 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 34.84 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 33.87 | 333.22 | 492.00 | 1,068.12 | 72.05 |
| Last | 34.23 | 333.97 | 495.47 | 1,068.55 | 72.17 |
| Change | +0.53 | +2.68 | +3.90 | +4.95 | -0.39 |
| % Change | +1.57% | +0.81% | +0.79% | +0.47% | -0.54% |
| Volume | 51,871 | 158,698 | 121,510 | 33,421 | 426,886 |
| 20-Day Average Volume | 294,851 | 2,005,890 | 1,093,947 | 411,949 | 6,248,009 |
| Previous Close | 33.70 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.15 | 321.00 | 481.72 | 1,064.51 | 69.80 |
| 20-Day Raw Stochastic | 76.14% | 88.74% | 84.70% | 64.61% | 76.77% |
| 20-Day Relative Strength | 74.68% | 68.18% | 65.88% | 58.48% | 63.98% |
| Weighted Alpha | +100.16 | +41.68 | +42.86 | +42.88 | -4.00 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 32% Buy | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.85% since 07/15/24 | +1.55% since 07/15/24 | +0.29% since 07/15/24 | -0.87% since 07/15/24 | +2.88% since 07/15/24 |
| Low | 32.81 on 07/16/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 37.28 on 07/19/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +41.54% since 06/21/24 | +8.80% since 06/21/24 | +5.02% since 06/21/24 | +1.86% since 06/21/24 | +3.08% since 06/21/24 |
| Low | 23.39 on 06/26/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 37.28 on 07/19/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | +72.79% since 04/22/24 | +23.31% since 04/22/24 | +23.09% since 04/22/24 | +19.17% since 04/22/24 | +8.81% since 04/22/24 |
| Low | 18.49 on 04/25/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 37.28 on 07/19/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | +43.03% since 01/22/24 | +8.10% since 01/22/24 | +11.85% since 01/22/24 | +13.78% since 01/22/24 | -7.11% since 01/22/24 |
| Low | 18.49 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 37.28 on 07/19/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 920,650 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 27,319 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 17,160,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -163,620,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 7,180,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -43,940,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | -0.25 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.64 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/05/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |